OncoResponse Raises $40.6 Million Series C Financing

Retrieved on: 2021-03-31 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

OncoResponse Raises $40.6 Million Series C Financing. View article details on hiswai:

Excerpt

SEATTLE, March 31, 2021 (GLOBE NEWSWIRE) -- OncoResponse, a biotechnology company harnessing the power of the human immune system to ...

Article found on: www.marketscreener.com